Yuanbin Song, M.D.^1*, Ashley Taylor, M.Sc.^1*, Anthony Rongvaux, Ph.D^2*, Tingting Jiang, Ph.D^3*, Nikolai A. Podoltsev, MD, PhD⁴, Mina Xu, M.D.^5*, Natalia Neparidze, MD^6*, Richard Torres, MD^7*, Lisa M Barbarotta, BSN, MSN, AOCNS, APRN-BC^1*, Kunthavai Balasubramanian, M.Sc.^1*, Karin E Finberg, MD, PhD⁸, Yuval Kluger, Ph.D^9*, Richard Flavell, Ph.D^10* and Stephanie Halene, MD¹

¹Section of Hematology/Department of Internal Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, CT
²Department of Immunobiology, Yale University School of Medicine, New Haven, CT
³Computational Bio & Bioinformatics, Yale University, New Haven, CT
⁴Dept of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
⁵Department of Pathology, Yale University School of Medicine, New Haven, CT
⁶Yale University/ VACT Cancer Center, West Haven, CT
⁷Department of Laboratory Medicine, Yale University, New Haven, CT
⁸Pathology, Yale School of Medicine, New Haven, CT
⁹Department of Pathology, Yale University, New Haven, CT
¹⁰Department of Immunobiology, Yale School of Medicine, New Haven, CT

Stephen S. Chung, MD¹, Priyanka Vijay^2*, Diana L. Stern^1*, Deirdre O'Sullivan^2*, Virginia M. Klimek, MD¹, Christopher Mason, PhD^2* and Christopher Y. Park, M.D., Ph.D.³

¹Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY
³Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY

Akihiro Tomita, MD, PhD¹, Yasuhiro Suzuki, MD^1,2*, Fumika Nakamura^1,3*, Chisako Iriyama, MD, PhD^1*, Mizuho Shirahata-Adachi, MD^1*, Kazuyuki Shimada, MD, PhD^1,4*, Akimi Akashi^1*, Yuichi Ishikawa, MD, PhD¹, Norio Kaneda, PhD^3* and Hitoshi Kiyoi, MD, PhD¹

¹Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
²Department of Hematology/Oncology Research, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
³Department of Analytical Neurobiology, Faculty of Pharmacy, Meijo University, Nagoya, Japan
⁴Institute for Adavanced Research, Nagoya University, Nagoya, Japan

Tomas Stopka, MD, PhD¹, Karina Vargova, MSc, PhD^2*, Vojtech Kulvait, MSc^2*, Jarmila Vargova, MSc^2*, Nina Dusilkova, MD^2* and Anna Jonasova, MD, PhD^3*

¹Haematology and Pathophysiology, Charles University and General Hospital in Prague, Prague, Czech Republic
²Pathophysiology, Charles University in Prague, Prague, Czech Republic
³Haematology, Charles University and General Hospital in Prague, Prague, Czech Republic

Brett M Stevens, PhD^*, Daniel Pollyea, MD, MS, Nabilah Khan, PhD^* and Craig T Jordan, PhD

Division of Hematology, University of Colorado School of Medicine, Aurora, CO

Evan M. Braunstein, MD, PhD¹, Ruijuan Li^2*, Nara Sobreira, MD^3*, Christopher Gocke, MD^4*, Robert A. Brodsky, MD⁵, David Valle, MD^4* and Linzhao Cheng, PhD⁶

¹Johns Hopkins University, Baltimore, MD
²Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Hunan, China
³Department of Pediatrics, Johns Hopkins University, Baltimore, MD
⁴Johns Hopkins, Baltimore, MD
⁵Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
⁶Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD

Manuel Buscarlet, PhD^1*, Sylvie Provost, MSc^2*, Vincent Bourgoin, MSc^1*, Luigina Mollica, MD, FRCPC, PhD^1,3,4 and Lambert Busque, MD, FRCPC, PhD^1,3,4

¹Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
²Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute Research Center, Montreal, QC, Canada
³Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
⁴Department of Medicine, University of Montreal, Montreal, QC, Canada

Susan Hilgendorf, MSc^1*, Hendrik Folkerts, MSc^1*, Jan Jacob Schuringa, PhD² and Edo Vellenga, MD, PhD¹

¹Department of Experimental Hematology, University Medical Center Groningen, Groningen, Netherlands
²Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Hiroko Sakurai, MD^1*, Yuka Harada, MD, PhD^1,2, Hirotaka Matsui, MD, PhD³, Hideaki Nakajima, MD, PhD⁴, Toshio Kitamura, MD, PhD⁵, Norio Komatsu, MD, PhD¹ and Hironori Harada, MD, PhD¹

¹Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
²Department of Clinical Laboratory Medicine, Bunkyo Gakuin University, Tokyo, Japan
³Department of Molecular Laboratory Medicine, Kumamoto University, Kumamoto, Japan
⁴Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
⁵Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Nathalie van Leeuwen-Kerkhoff, MD^1*, Theresia M. Westers, PhD^1*, Hetty J Bontkes, PhD^2*, Shahram Kordasti, MD, PhD^3,4*, Ghulam J. Mufti, MD, PhD^5,6, Tanja D de Gruijl, PhD^7* and Arjan A van de Loosdrecht, MD, PhD¹

¹Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
²Department of Pathology, VU University Medical Center, Amsterdam, Netherlands
³Haematological Medicine, King's College Hospital, London, United Kingdom
⁴Department of Haematological Medicine, King's College London, London, United Kingdom
⁵King's College Hospital, London, United Kingdom
⁶Haematological Medicine, King's College London, London, United Kingdom
⁷Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

Tran Ngoc-Tung^1*, Hairui Su, BS², Yuheng Lu^3*, Christina S Leslie, PhD^4* and Xinyang Zhao, PhD⁵

¹Stem Cell Institute, The University of Alabama at Birmingham, Birmingham, AL
²UAB Stem Cell Institute, Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, AL
³computational biology program, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL

Niroshan Nadarajah, M.Sc.^*, Manja Meggendorfer, PhD^*, Wolfgang Kern, MD, Claudia Haferlach, MD and Torsten Haferlach

MLL Munich Leukemia Laboratory, Munich, Germany

Albert Perez-Ladaga, PhD^1*, Huafeng Xie, PhD^2*, Stuart H. Orkin, M.D.³, David B. Sykes, MD, PhD⁴, Benjamin L. Ebert, MD, PhD⁵ and Rafael Bejar, MD, PhD¹

¹UCSD Moores Cancer Center, La Jolla, CA
²The Harvard Clinical and Translational Science Center, Boston, MA
³Department of Pediatric Hematology-Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
⁵Division of Hematology, Brigham and Women's Hospital, Boston, MA

Manuel Buscarlet, PhD^1*, Alain Tessier^2*, Sylvie Provost, MSc^3* and Lambert Busque, MD, FRCPC^1,4,5

¹Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
²Centre for Biological Application of Mass Spectrometry, Concordia University, Montreal, QC, Canada
³Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute Research Center, Montreal, QC, Canada
⁴Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
⁵Department of Medicine, University of Montreal, Montreal, QC, Canada

Guntram Buesche, MD¹, Aristoteles Giagounidis, MD, PhD², Gudrun Göhring, M.D.^3*, Brigitte Schlegelberger, MD, Prof.³, Arnold Ganser, M.D.⁴, Carlo Aul, MD^5* and Hans Heinrich Kreipe, M.D.^6*

¹Department of Pathology, Hannover Medical School, Hannover, Germany
²Marien Hospital Düsseldorf, Düsseldorf, Germany
³Institute of Human Genetics, Hannover Medical School, Hannover, Germany
⁴Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁵Klinik für Onkologie und Hämatologie, HELIOS St. Johannes Klinik, Duisburg, Germany
⁶Institute of Pathology, Hannover Medical School, Hannover, Germany

Yoko Nishinaka-Arai, Ph.D.^1*, Akira Niwa, M.D., Ph.D.^2*, Mitsujiro Osawa, Ph.D.², Tatsutoshi Nakahata, M.D., Ph.D.³ and Megumu K Saito, M.D., Ph.D.^2*

¹Clinical Application Department, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
²Center for iPS cell Research and Application, Kyoto University, Kyoto, Japan
³Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan

Kimihito Cojin Kawabata, MD, PhD^1*, Daichi Inoue, MD, PhD^1*, Jiro Kitaura, MD, PhD^1,2*, Yuka Harada, MD, PhD³, Susumu Goyama, MD, PhD¹, Hironori Harada, MD, PhD⁴, Hiroyuki Aburatani, MD, PhD^5* and Toshio Kitamura, MD, PhD¹

¹Institute of Medical Science, Division of Cellular Therapy, The University of Tokyo, Tokyo, Japan
²School of Medicine, Juntendo University, Tokyo, Japan
³Department of Clinical Laboratory Medicine, Bunkyo Gakuin University, Tokyo, Japan
⁴Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
⁵Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan

Toshio Asayama, MD^1*, Mariko Ishibashi, PhD^1*, Hideto Tamura, MD, PhD¹, Yasuko Hamada, MD^1*, Namiko Okuyama, MD^1*, Asaka Onodera, MD, PhD^1*, Akiko Yamada, MD^1*, Keiichi Moriya, MD, PhD^1*, Norio Yokose, MD, PhD^2* and Koiti Inokuchi, PhD, MD¹

¹Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
²Division of Hematology, Department of Internal medicine, Chiba Hokusoh Hospital, Nippon Medical School Chiba Hokusos Hospital, Chiba, Japan

Huojun Cao^1*, Zheng Yin, PhD^2*, Shenyi Chen^1*, Timothy Liu^1*, Jiyong Liu^1*, Yaping Hu^1*, Hong Zhao¹, Lawrence Rice, MD³, Swaminathan Padmanabhan Iyer, MD⁴ and Stephen Wong^1*

¹Houston Methodist Research Institute, Weill Cornell Medical College, Houston
²Houston Methodist Research Institute, Houston, TX
³Department of Medicine, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX
⁴Hematology, Early Drug Development, Houston Methodist Cancer Center/Weill Cornell Medical College, Houston, TX

Jan Valka, MD^1*, Monika Belickova^2*, Jitka Vesela^3*, Eliska Stara^1*, Barbora Pejsova^1* and Anna Jonasova, MD, PhD^4*

¹Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
²Institute of Hematology and Blood Transfusion, Prague, Czech Republic
³Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
⁴Haematology, Charles University and General Hospital in Prague, Prague, Czech Republic

Hsiao-Wen Kao, MD^1*, Ming-Chung Kuo, MD^2*, Po-Nan Wang, MD³, Jin-Hou Wu, MD^4*, Tung-Huei Lin, MS^3*, Yu-Shu Shih, MS^4*, Der-Cherng Liang, MD⁵ and Lee-Yung Shih, MD²

¹Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
²Chang Gung Memorial Hospital-Linkou and Chang Gung University, Taoyuan, Taiwan
³Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan
⁴Chang Gung Memorial Hospital, Taoyuan, Taiwan
⁵Mackay Memorial Hospital, Taipei, Taiwan

Nguyen Johnny, MD^1*, Kathy L McGraw, Ph.D.², Rami S. Komrokji, MD³, David Sallman, M.D.⁴, Najla H. Al Ali, BDS, MSc^3*, Eric Padron, MD³, Jeffrey E Lancet, MD³, Lynn C. Moscinski, M.D.⁵, Alan F. List, MD⁶ and Ling Zhang, MD⁷

¹H. Lee Moffitt Cancer Center and Research Institute, University, Tampa, FL
²H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
³Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁴Dept. of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁵Dept. of Hematopathology, Moffitt Cancer Center, Tampa, FL
⁶Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Christine Victoria Ichim, PhD^1*, Dzana Dervovic, PhD^2*, David Raymond Koos, PhD^3* and Richard A. Wells, MD, DPhil⁴

¹Department of Molecular Therapeutics, Regen BioPharma Inc., San Diego, CA
²Department of Immunology, University of Toronto, Toronto, ON, Canada
³Regen BioPharma Inc., San Diego, CA
⁴Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Frank G. Rücker, MD^1*, Sibylle Cocciardi^1*, Anna Dolnik, PhD^1*, Tamara J. Blätte^1*, Ulrike Wüst^2*, Peter Paschka, MD¹, Verena I. Gaidzik, MD^1*, Richard F. Schlenk, MD², Hartmut Döhner, Prof. Dr.¹, Lars Bullinger, MD¹ and Konstanze Döhner, MD¹

¹Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
²University Hospital of Ulm, Ulm, Germany